Adjuvant Therapies and Markers of Post-Surgical Minimal Residual Disease I : Markers and General Problems of Cancer Adjuvant Therapies

P. Denoix and G. Mathe Approximately 70% of cancer patients relapse after surgery before the 5th year and, in most cases, for example in breast carcinoma, they relapse still later up to the 20th year. For some considerable time, the strategy of cancer treatment has been limited to the sophistication...

Full description

Main Author: Bonadonna, Gianni
Corporate Author: SpringerLink (Online service)
Other Authors: Mathé, Georges (Editor), Salmon, Sydney E. (Editor)
Format: eBook
Published: Berlin, Heidelberg Springer Berlin Heidelberg 1979, 1979
Series:Recent Results in Cancer Research, Fortschritte der Krebsforschung Progrès dans les recherches sur le cancer
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
Table of Contents:
  • A Serum Enzyme Marker in the Follow-Up of Cancer Patients
  • Evidence for Natural Antibodies (IgG) to Poly amines in Human Sera
  • Dynamic and Composition of Cellular Membranes and Serum Lipids in Malignant Disorders
  • Biologic Markers in Neuroblastoma
  • Immune Complexes in Breast Carcinoma
  • Serum Leukocyte Inhibitory Factor in Cancer Patients (Serum LIF)
  • Clinical Evaluation of the Modified Markari Skin Test in Minimal Residual Malignant Disease
  • Multiparametric Markers